1,505 research outputs found
Казахстан на страницах Туркестанского сборника
Presently most adolescent anxiety disorder screening instruments make their determination of running a high risk for an anxiety disorder on the basis of a cut-off score measured by a single screening which can lead to false positives. Therefore, the goal of this study is to examine whether a repeated administration of the SCARED screening instrument for DSM-5 anxiety disorder symptoms could help in the detection of true positives while also avoiding false positives. Participants were 923 early adolescents from the general community. The adolescents’ ages at the first annual screening ranged from 10 to 15 with an average of 12.5 years. In a prospective five-year longitudinal design, the adolescents completed the SCARED screening instrument for anxiety disorder symptoms on a yearly basis. To detect true positives and avoid false positives, the data were analyzed with Receiver Operating Characteristics (ROC) cut-off score analyses. ROC cut-off score analyses revealed that the sensitivity and specificity of high risk were greatly improved for repeated screenings above those of a single screening. The findings of this study demonstrate that a screening instrument (such as the SCARED) should be administered not just once but several times in order to better determine true positives and avoid false positives
Recommended from our members
Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions.
ObjectiveTo determine the transfer of rituximab, an anti-CD20 monoclonal antibody widely used for neurologic conditions, into mature breast milk.MethodsBreast milk samples were collected from 9 women with MS who received rituximab 500 or 1,000 mg intravenous once or twice while breastfeeding from November 2017 to April 2019. Serial breast milk samples were collected before infusion and at 8 hours, 24 hours, 7 days, and 18-21 days after rituximab infusion in 4 patients. Five additional patients provided 1-2 samples at various times after rituximab infusion.ResultsThe median average rituximab concentration in mature breast milk was low at 0.063 μg/mL (range 0.046-0.097) in the 4 patients with serial breast milk collection, with an estimated median absolute infant dose of 0.0094 mg/kg/d and a relative infant dose (RID) of 0.08% (range 0.06%-0.10%). Most patients had a maximum concentration at 1-7 days after infusion. The maximum concentration occurred in a woman with a single breast milk sample and was 0.29 μg/mL at 11 days postinfusion, which corresponds with an estimated RID of 0.33%. Rituximab concentration in milk was virtually undetectable by 90 days postinfusion.ConclusionsWe determined minimal transfer of rituximab into mature breast milk. The RID for rituximab was less than 0.4% and well below theoretically acceptable levels of less than 10%. Low oral bioavailability would probably also limit the absorption of rituximab by the newborn. In women with serious autoimmune neurologic conditions, monoclonal antibody therapy may afford an acceptable benefit to risk ratio, supporting both maternal treatment and breastfeeding
Direct aggression and generalized anxiety in adolescence:Heterogeneity in development and intra-individual change
Co-occurrence of aggression and anxiety might change during adolescence, or stay stable. We studied change and stability of four types of co-occurrence regarding direct aggression and anxiety in adolescence: an anxious and non-aggressive type, an aggressive and non-anxious type, a comorbid aggressive-anxious type and a no problems type. We applied a person-centered approach to assess increases and decreases of these types, and tested various models of intra-individual change of the types: the stability, acting out and failure models. We used data from a five-wave study of 923 early-to-middle and 390 middle-to-late adolescents (48.5 % male), thereby covering the ages of 12–20. We observed accelerated development in the older cohort: adolescents tended to grow faster out of the aggressive types in middle-to-late adolescence than in early-to-middle adolescence. We observed one other group-dependent pattern of heterogeneity in development, namely “gender differentiation”: gender differences in aggression and generalized anxiety became stronger over time. We found support for two perspectives on intra-individual change of the four types, namely the stability and the acting out perspective. The no problems—and to a lesser extent the anxious—type proved to be stable across time. Acting out was found in early-to-middle adolescents, males, and adolescents with poorer-quality friendships. In all three groups, there were substantial transitions from the anxious type to the aggressive type during 4 years (between 20 and 41 %). Remarkably, acting out was most prevalent in subgroups that, generally speaking, are more vulnerable for aggressive behavior, namely early-to-middle adolescents and males. We interpret acting out as the attempt of adolescents to switch from anxiety to instrumental aggression, in order to become more visible and obtain an autonomous position in the adolescent world. Acting out contributed to the explanation of accelerated development and gender differentiation. We also observed an increase of adolescents with no problems. These findings highlight that the co-occurrence of aggression and anxiety changes considerably during adolescence, but also that the anxious and no problems types are quite stable in this period. Keywords: Direct aggression Generalized anxiety Adolescence Longitudinal researc
Across-sectional study on the prevalence of Thai adolescent depression
This large-scale study aimed to investigate the prevalence of depression in 4,089 Thai adolescents of both sexes. The participants were between 11 and 16 years old and sampled from all the various regions of Thailand to be representative of the entire country. The Thai translation of the Patient Health Questionnaire for Adolescents (PHQ-A) was employed to collect data. Descriptive statistics and chi-square tests of independence were used for data analysis. The results revealed that the vast majority of the participants (72.2%) had either a mild (44.5%; PHQ-A = 5–9) or at least a moderate form of depression (27.7 %; PHQ-A ≥ 10). Further analysis found that females (χ2 = 41.9, p =.000), poor academic results (χ2 = 12.7, p = .013), low family income (χ2 = 18.0, p =.021), suicidal thoughts (χ2 = 811.0, p =.000) and suicide attempts (χ2 = 414.4, p =.000) were associated with depression, while age (χ2 = 8.9, p = .064) was not associated with depression. Compared to worldwide PHQ-A-based studies of adolescent depression, it would appear that the prevalence of depression in Thai adolescents is common and relatively high
Ontwikkelingstrajecten van angstsymptomen: Een vijfjarig prospectief onderzoek onder adolescenten in de algemene populatie
Achtergrond: Het relatief recente gebruik van moderne statistische analysemethoden zoals een latent groeimodel (lgm) maakt het mogelijk om verschillen in individuele ontwikkelingstrajecten over tijd te bestuderen.
doel Prospectief en longitudinaal onderzoeken van de ontwikkelingstrajecten van angstsymptomen over een periode van vijf jaar in een grote steekproef (n = 1318) uit de algemene
adolescentenpopulatie.
Methode: Er werd onderscheid gemaakt tussen een cohort jongeren in de vroege adolescentie (gemiddeld 12 jaar oud tijdens de eerste meting) en in de midden adolescentie (gemiddeld 16 jaar oud tijdens de eerste meting). Leeftijds- en sekseverschillen in de ontwikkelingstrajecten van
angstsymptomen werden onderzocht met lgm.
resultaten Uit de analyses bleek dat de symptomen van de paniekstoornis, schoolangst en separatieangst voor alle adolescent
Personality and anxiety associations in adolescents and emerging adults
This study was aimed at unraveling associations between Big Five personality traits and anxiety symptoms of panic, generalized anxiety disorder, school phobia, separation anxiety, and social phobia in male and female adolescents and emerging adults from the general population. Participants were 3,758 (54.6% females) adolescents and emerging adults aged between 11 and 26 years. They completed the shortened Big Five questionnaire and the Screen for Child Anxiety Related Emotional Disorders. Results indicated that the associations between Big Five and anxiety symptoms were consistent across gender and age groups. Most of the associations were statistically significant with the strongest links found between extraversion and symptoms of social phobia; conscientiousness and symptoms of school anxiety; and emotional stability and symptoms of panic, separation, generalized, and school anxiety. All these associations were negative, suggesting that higher levels of these personality traits were related to lower levels of anxiety symptoms
URB597 induces subtle changes to aggression in adult Lister Hooded rats
The endocannabinoid system has been implicated in both social and cognitive processing. The endocannabinoid metabolism inhibitor, URB597, dose-dependently improves non-social memory in adult Wistar and Sprague Dawley rats, whereas its effect on social interaction (SI) is affected by both rat strain and drug dose. Lister Hooded rats consistently respond differently to drug treatment in general compared with albino strains. This study sought to investigate the effects of different doses of URB597 on social and non-social memory in Lister Hooded rats, as well as analyzing the behavioral composition of the SI. Males were tested for novel object recognition (NOR), social preference (between an object and an unfamiliar rat), social novelty recognition (for a familiar vs. unfamiliar rat) and SI with an unfamiliar rat. URB597 (0.1 or 0.3 mg/kg) or vehicle was given 30 min before testing. During SI testing, total interaction time was assessed along with time spent on aggressive and explorative behaviors. Lister Hooded rats displayed expected non-social and social memory and social preference, which was not affected by URB597. During SI, URB597 did not affect total interaction time. However, the high dose increased aggression, compared to vehicle, and decreased anogenital sniffing, compared to the low dose of URB597. In summary, URB597 did not affect NOR, social preference or social recognition memory but did have subtle behavioral effects during SI in Lister hooded rats. Based on our findings we argue for the importance of considering strain as well as the detailed composition of behavior when investigating drug effects on social behavior
Leptin is a four-helix bundle: secondary structure by NMR
AbstractLeptin is a signaling protein that in its mutant forms has been associated with obesity and Type II diabetes. The lack of sequence similarity has precluded analogies based on structural resemblance to known systems. Backbone NMR signals for mouse leptin (13C/15N -labeled) have been assigned and its secondary structure reveals it to be a four-helix bundle cytokine. Helix lengths and disulfide pattern are in agreement with leptin as a member of the short-helix cytokine family. A three-dimensional model was built verifying the mechanical consistency of the identified elements with a short-helix cytokine core
Endocannabinoid metabolism inhibition has no effect on spontaneous fear recovery or extinction resistance in Lister hooded rats
Endocannabinoid transmission is emerging as a target for treating anxiety-related disorders, given its regulation of fear extinction. Boosting anandamide levels via inhibition of its metabolism by fatty acid amide hydrolase (FAAH) can enhance extinction, whereas inhibiting monoacylglycerol lipase (MAGL) to elevate 2-arachidonoylglycerol levels can impair extinction. However, whether endocannabinoids regulate fear relapse over time or extinction resistance remains unclear. In two experiments using auditory fear conditioned rats, we examined the effects of the FAAH inhibitor URB597 and the MAGL inhibitor JZL184 administered systemically on 1) spontaneous fear recovery after delayed extinction, and 2) extinction resistance resulting from immediate extinction [the immediate extinction deficit (IED)]. In Experiment 1, URB597 or JZL184 was given immediately after delayed extinction occurring 24 h after conditioning. Extinction recall and spontaneous fear recovery were tested drug-free 1 and 21 days later, respectively. We found no effects of either drug on extinction recall or spontaneous fear recovery. In Experiment 2, URB597 or JZL184 was given before immediate extinction occurring 30 min after conditioning and extinction recall was tested drug-free the next day. We also examined the effects of propranolol, a beta-adrenoceptor antagonist that can rescue the IED, as a positive control. JZL184 enhanced fear expression and impaired extinction learning but we found no lasting effects of URB597 or JZL184 on cued extinction recall. Propranolol reduced fear expression but, unexpectedly, had no enduring effect on extinction recall. The results are discussed in relation to various methodological differences between previous studies examining endocannabinoid and adrenergic regulation of fear extinction
- …